SCHEMBL6786192

SCHEMBL6786192

Cn1ncc2[nH]c3ccc(Cc4ccccc4O)cc3c(=O)c21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.36
MEN1 O00255 2/20 0.35
POLB P06746 2/20 0.35
KMT2A Q03164 2/20 0.35
GAA P10253 1/20 0.35
CASP6 P55212 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
IDH1 O75874 1/20 0.34
CYP1A2 P05177 1/20 0.34
GABRA1 P14867 3/20 0.34
GABRB2 P47870 3/20 0.34
DAO P14920 1/20 0.33
DDO Q99489 1/20 0.33
MAPK1 P28482 1/20 0.33
GABRB1 P18505 1/20 0.33
GABRA3 P34903 1/20 0.33
NPC1 O15118 1/20 0.33
KIF11 P52732 1/20 0.32
HSPA5 P11021 1/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6784689 0.87 PRMT5 (0.37) MEN1POLBKMT2AKDM4E
SCHEMBL6791754 0.87 BPTF (0.35) MEN1POLBKMT2AGABRA1GABRB2
SCHEMBL6788322 0.87 AR (0.37) MEN1POLBKMT2AGABRA1GABRB2
Hydrochloric Acid SCHEMBL6782358 0.86 BPTF (0.35) MEN1POLBKMT2AGABRA1GABRB2
SCHEMBL6783054 0.86 MAPK1 (0.32) MEN1POLBKMT2AGABRA1GABRB2
Hydrochloric Acid SCHEMBL6782998 0.86 AR (0.36) MEN1POLBKMT2AGABRA1GABRB2
SCHEMBL6787085 0.85 GABRA1 (0.36) GABRA1GABRB2GABRB1GABRA3KDM4E
SCHEMBL6785795 0.85 GABRA1 (0.44) POLBGABRA1GABRB2MAPK1GABRB1
SCHEMBL6786229 0.85 ATM (0.42) MEN1POLBKMT2AGAAIDH1
SCHEMBL6785194 0.85 HTR2A (0.37) MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686373-B2 ANALGESICS; ANTIINFLAMMATORY AGENT WARNER-LAMBERT COMPANY LLC 2004-02-03 US disclosed
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors KAWAMURA KIYOSHI (JP) 2003-07-10 US disclosed
EP-1310498-A2 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PFIZER INC. (US) 2003-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PRKCB, PRKCA, PRKCG KEAP1 522/4885MEN1 4326/4885POLB 4021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.